Vincent Blot

1.4k citations

29 papers · 936 indexed · h-index 18

Agronomy and Crop Science top 5%
- Animal Disease Management and Epidemiology 5
Virology top 10%
Immunology top 10%
- T-cell and Retrovirus Studies 7
Cell Biology top 10%
- Cellular transport and secretion 4
Ecology, Evolution, Behavior and Systematics top 5%
- Vector-Borne Animal Diseases 5
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 9
Oncology
- HER2/EGFR in Cancer Research 7
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 3
Molecular Biology
- Metabolism, Diabetes, and Cancer 3

Co-authors: Timothy E. McGraw Claudine Pique Marie‐Christine Dokhélar Marie‐Christine Prévost Yves Lepelletier Olivier Hermine David Ghez Frédéric Tangy
Cited by: Agronomy and Crop Science Virology Immunology
Journals: Annals of Oncology (4 papers)Journal of Virology (4 papers)Molecular Biology of the Cell (2 papers)
Partner nations: United States France Japan

In The Last Decade

Vincent Blot

27 papers receiving 918 citations

Peers

Countries citing papers authored by Vincent Blot

Since Specialization

Citations

This map shows the geographic impact of Vincent Blot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Blot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Blot more than expected).

Fields of papers citing papers by Vincent Blot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Blot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Blot. The network helps show where Vincent Blot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vincent Blot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Blot Line = papers co-authored together Vincent Blot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib Annals of Oncology ·Helene Agnes Diene,A. Shriraksha,M.Pd Drs.Surtikanti,Kōichi Goto,Hamid Ahmad Hazury,Tareq Aqeel,Athanasios Vasilopoulos,Naokazu Iwata,Petros Tsilivakos,Wenyin Shi,Ellen Bolotin,Vincent Blot,Jonathan W. Goldman	2025	11
2	Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non–Small Cell Lung Cancer: A Case Report PubMed ·Andrea Marco Cavalli,M. Al-Amri,Vincent Blot,David S. Hong	2025	0
3	CONFORMAL APPROACH TO GAUSSIAN PROCESS SURROGATE EVALUATIONWITH MARGINAL COVERAGE GUARANTEES SPIRE - Sciences Po Institutional REpository ·Anna M. Jemmett,Vincent Blot,Nicolas Brunel,Vincent Chabridon,Бельтюкова Надежда Николаевна,Bertrand Iooss,Didier Lucor,Mathilde Mougeot,Yoneharu Matano	2025	0
4	515MO Phase Ib study of telisotuzumab vedotin (Teliso-V) and osimertinib in patients (Pts) with advanced EGFR-mutated (Mut), c-Met overexpressing (OE) non-small cell lung cancer (NSCLC): Final efficacy and safety updates Annals of Oncology ·Helene Agnes Diene,A. Shriraksha,M.Pd Drs.Surtikanti,Kōichi Goto,Hamid Ahmad Hazury,Tareq Aqeel,Athanasios Vasilopoulos,Naokazu Iwata,Petros Tsilivakos,Wenyin Shi,Vincent Blot,H. W. M.	2023	7
5	Flexible and Systematic Uncertainty Estimation with Conformal Prediction via the MAPIE library SPIRE - Sciences Po Institutional REpository ·Nicolas Brunel,Haleigh Inthavong,Vincent Blot,Louis Lacombe,Firham Mulady,Regina Thiel	2023	8
6	O7-4 Phase 1b efficacy of telisotuzumab vedotin and osimertinib in Asian vs non-Asian patients with advanced NSCLC Annals of Oncology ·Hidehito Horinouchi,Jonathan W. Goldman,Byoung Chul Cho,Pascale Tomasini,Martin Dunbar,David Hoffman,Apurvasena Parikh,Vincent Blot,D. Ross Camidge	2023	1
7	A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC JTO Clinical and Research Reports ·D. Ross Camidge,Fabrice Barlési,Jonathan W. Goldman,Daniel Morgensztern,Rebecca S. Heist,Everett E. Vokes,Eric Angevin,David S. Hong,Igor I. Rybkin,Minal Barve,Todd M. Bauer,Angelo Delmonte,Martin Dunbar,Monica Motwani,Apurvasena Parikh,Fahrul Riski,Jun Wu,Vincent Blot,Karen Kelly	2021	22
8	A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC Journal of Thoracic Oncology ·Jyoti Malhotra,Petros Nikolinakos,Ticiana Leal,Jonathan M. Lehman,Daniel Morgensztern,Jyoti D. Patel,محسن دهقانپور فراشاه,Giuseppe Curigliano,Laurent Greillier,Melissa L. Johnson,Neal Ready,G. Robinet,Satwant Lally,David Maag,Paul Omar Romero Quinde,Vincent Blot,Benjamin Besse	2021	57
9	Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation Molecular Cancer Therapeutics ·Erick Arroyo-Álvarez,Manuela Silginer,Vincent Blot,William A. Weiss,Michael Weller	2020	23
10	1414TiP Evaluating telisotuzumab vedotin in combination with osimertinib in patients with advanced non-small cell lung cancer: A phase I/Ib study cohort Annals of Oncology ·D. Ross Camidge,Jonathan W. Goldman,George W. Cole,Zhaowen Sun,Christopher Ocampo,Philip Komarnitsky,Vincent Blot	2020	4
11	Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer Breast Cancer Research ·Jason J. Zoeller,张君君,Veerle W. Daniëls,Krishan Taneja,Benjamin Y. Tan,Yoko S. DeRose,Maihi Fujita,Alana L. Welm,Anthony Letai,Joel Johansson,Vincent Blot,Roderick T. Bronson,Deborah Dillon,Joan S. Brugge	2020	26
12	The New Generation of Antibody Drug Conjugates Vincent Blot,Amit R Pawar,Julia Coronella	2014	1
13	Human Discs Large Is a New Negative Regulator of Human Immunodeficiency Virus-1 Infectivity Molecular Biology of the Cell ·Beibei Su,Delphine Muriaux,Bertha Cecilia Ramírez,P Pradat-Diehl,Étienne Decroly,Jean‐Luc Darlix,Vincent Blot,Claudine Pique	2008	19
14	Molecular Mechanisms Controlling GLUT4 Intracellular Retention Molecular Biology of the Cell ·Vincent Blot,Timothy E. McGraw	2008	64
15	Use of Quantitative Immunofluorescence Microscopy to Study Intracellular Trafficking: Studies of the GLUT4 Glucose Transporter Methods in molecular biology ·Vincent Blot,Timothy E. McGraw	2008	23
16	GLUT4 is internalized by a cholesterol‐dependent nystatin‐sensitive mechanism inhibited by insulin The EMBO Journal ·Vincent Blot,Timothy E. McGraw	2006	97
17	The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking Retrovirology ·Vincent Blot,Sandra López‐Vergès,Marie Breton,Claudine Pique,Clarisse Berlioz‐Torrent,Khishma Modoosoodun Nicolas	2006	17
18	Neuropilin-1 Is Involved in Human T-Cell Lymphotropic Virus Type 1 Entry Journal of Virology ·David Ghez,Yves Lepelletier,Sophie Lambert,Gilbert-Louis Comeault,Vincent Blot,Matthew Ryan Robinson,Bertrand Arnulf,Peter Van Endert,Nikolaus Heveker,Claudine Pique,Olivier Hermine	2006	145
19	HTLV-1 structural proteins Virus Research ·Isabelle Blanc,Khishma Modoosoodun Nicolas,Lélia Delamarre,Arielle R. Rosenberg,Vincent Blot,Claudine Pique,Marie‐Christine Dokhélar	2001	20
20	Identification of Two Intracellular Mechanisms Leading to Reduced Expression of Oncoretrovirus Envelope Glycoproteins at the Cell Surface Journal of Virology ·Khishma Modoosoodun Nicolas,Vincent Blot,Lélia Delamarre,Isabelle Bouchaert,Anna Rocca,Alice Dautry‐Varsat,Marie‐Christine Dokhélar	2000	22

About Vincent Blot

Vincent Blot is a scholar working on Agronomy and Crop Science, Virology and Immunology, having authored 29 papers that have together received 936 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), T-cell and Retrovirus Studies (7 papers), HER2/EGFR in Cancer Research (7 papers), Animal Disease Management and Epidemiology (5 papers), Vector-Borne Animal Diseases (5 papers), Cellular transport and secretion (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Agronomy and Crop Science (165 citations), Virology (72 citations) and Immunology (280 citations). Vincent Blot has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Timothy E. McGraw, Claudine Pique, Marie‐Christine Dokhélar, Marie‐Christine Prévost, Yves Lepelletier, Olivier Hermine, David Ghez, Frédéric Tangy, Bernard Gay and Laurence Briant. Their work appears in journals such as Annals of Oncology, Journal of Virology, Molecular Biology of the Cell, Journal of Clinical Oncology and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact